Vanguard Asset Management’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
Other funds holding DYN
Vanguard Asset Management's DYN Position: Q3 2026 in Review
Vanguard Asset Management increased its Dyne Therapeutics (DYN) stake by 23% in Q3 2026, buying an estimated $423K and bringing the position to 99,657 shares worth $1.61M. The position accounts for ﹤0.01% of the portfolio, ranked #1665.
Vanguard Asset Management first reported a position in DYN in Q1 2026 and has held it in 3 quarters since. The position peaked at $1.8M in Q2 2026. 260 funds tracked by Wall St. Rank hold DYN as of Q3 2026.
- Vanguard Asset Management held 99,657 shares of Dyne Therapeutics worth $1.61M as of Q3 2026.
- Vanguard Asset Management bought 18,419 Dyne Therapeutics shares in Q3 2026, an estimated $423K.
- Dyne Therapeutics made up ﹤0.01% of Vanguard Asset Management's portfolio in Q3 2026, its #1665 holding.
- Vanguard Asset Management first reported a position in Dyne Therapeutics in Q1 2026 and has held it in 3 quarters since.
- Vanguard Asset Management's Dyne Therapeutics position peaked at $1.8M in Q2 2026.
- 260 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q3 2026.
Based on Vanguard Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.